These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1123 related items for PubMed ID: 27655848

  • 1. Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice.
    Rao A, Kosters A, Mells JE, Zhang W, Setchell KD, Amanso AM, Wynn GM, Xu T, Keller BT, Yin H, Banton S, Jones DP, Wu H, Dawson PA, Karpen SJ.
    Sci Transl Med; 2016 Sep 21; 8(357):357ra122. PubMed ID: 27655848
    [Abstract] [Full Text] [Related]

  • 2. Lactoferrin promotes bile acid metabolism and reduces hepatic cholesterol deposition by inhibiting the farnesoid X receptor (FXR)-mediated enterohepatic axis.
    Ling CJ, Xu JY, Li YH, Tong X, Yang HH, Yang J, Yuan LX, Qin LQ.
    Food Funct; 2019 Nov 01; 10(11):7299-7307. PubMed ID: 31626262
    [Abstract] [Full Text] [Related]

  • 3. A novel ASBT inhibitor, IMB17-15, repressed nonalcoholic fatty liver disease development in high-fat diet-fed Syrian golden hamsters.
    Ge MX, Niu WX, Ren JF, Cai SY, Yu DK, Liu HT, Zhang N, Zhang YX, Wang YC, Shao RG, Wang JX, He HW.
    Acta Pharmacol Sin; 2019 Jul 01; 40(7):895-907. PubMed ID: 30573812
    [Abstract] [Full Text] [Related]

  • 4. Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease.
    Jiang C, Xie C, Li F, Zhang L, Nichols RG, Krausz KW, Cai J, Qi Y, Fang ZZ, Takahashi S, Tanaka N, Desai D, Amin SG, Albert I, Patterson AD, Gonzalez FJ.
    J Clin Invest; 2015 Jan 01; 125(1):386-402. PubMed ID: 25500885
    [Abstract] [Full Text] [Related]

  • 5. Pectin Penta-Oligogalacturonide Suppresses Intestinal Bile Acids Absorption and Downregulates the FXR-FGF15 Axis in High-Cholesterol Fed Mice.
    Zhu R, Hou Y, Sun Y, Li T, Fan J, Chen G, Wei J.
    Lipids; 2017 Jun 01; 52(6):489-498. PubMed ID: 28474246
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of ileal bile acid transport and reduced atherosclerosis in apoE-/- mice by SC-435.
    Bhat BG, Rapp SR, Beaudry JA, Napawan N, Butteiger DN, Hall KA, Null CL, Luo Y, Keller BT.
    J Lipid Res; 2003 Sep 01; 44(9):1614-21. PubMed ID: 12810816
    [Abstract] [Full Text] [Related]

  • 7. Trimethylamine N-Oxide Aggravates Liver Steatosis through Modulation of Bile Acid Metabolism and Inhibition of Farnesoid X Receptor Signaling in Nonalcoholic Fatty Liver Disease.
    Tan X, Liu Y, Long J, Chen S, Liao G, Wu S, Li C, Wang L, Ling W, Zhu H.
    Mol Nutr Food Res; 2019 Sep 01; 63(17):e1900257. PubMed ID: 31095863
    [Abstract] [Full Text] [Related]

  • 8. Editor's Highlight: Clofibrate Decreases Bile Acids in Livers of Male Mice by Increasing Biliary Bile Acid Excretion in a PPARα-Dependent Manner.
    Zhang Y, Lickteig AJ, Csanaky IL, Klaassen CD.
    Toxicol Sci; 2017 Dec 01; 160(2):351-360. PubMed ID: 28973556
    [Abstract] [Full Text] [Related]

  • 9. Bile acids contribute to the development of non-alcoholic steatohepatitis in mice.
    Gillard J, Clerbaux LA, Nachit M, Sempoux C, Staels B, Bindels LB, Tailleux A, Leclercq IA.
    JHEP Rep; 2022 Jan 01; 4(1):100387. PubMed ID: 34825156
    [Abstract] [Full Text] [Related]

  • 10. Cholesterol feeding prevents hepatic accumulation of bile acids in cholic acid-fed farnesoid X receptor (FXR)-null mice: FXR-independent suppression of intestinal bile acid absorption.
    Miyata M, Matsuda Y, Nomoto M, Takamatsu Y, Sato N, Hamatsu M, Dawson PA, Gonzalez FJ, Yamazoe Y.
    Drug Metab Dispos; 2009 Feb 01; 37(2):338-44. PubMed ID: 18988759
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of ileal bile acid transport lowers plasma cholesterol levels by inactivating hepatic farnesoid X receptor and stimulating cholesterol 7 alpha-hydroxylase.
    Li H, Xu G, Shang Q, Pan L, Shefer S, Batta AK, Bollineni J, Tint GS, Keller BT, Salen G.
    Metabolism; 2004 Jul 01; 53(7):927-32. PubMed ID: 15254889
    [Abstract] [Full Text] [Related]

  • 12. Mitigation of high-fat diet-induced hepatic steatosis by thyme (Thymus quinquecostatus Celak) polyphenol-rich extract (TPE): insights into gut microbiota modulation and bile acid metabolism.
    Sheng X, Zhan P, Wang P, He W, Tian H.
    Food Funct; 2024 Jul 15; 15(14):7333-7347. PubMed ID: 38305590
    [Abstract] [Full Text] [Related]

  • 13. Nuciferine Protects Against High-Fat Diet-Induced Hepatic Steatosis via Modulation of Gut Microbiota and Bile Acid Metabolism in Rats.
    Sun J, Fan J, Li T, Yan X, Jiang Y.
    J Agric Food Chem; 2022 Sep 28; 70(38):12014-12028. PubMed ID: 36106619
    [Abstract] [Full Text] [Related]

  • 14. Hepatic cholesterol accumulation ascribed to the activation of ileum Fxr-Fgf15 pathway inhibiting hepatic Cyp7a1 in high-fat diet-induced obesity rats.
    Duan Y, Zhang F, Yuan W, Wei Y, Wei M, Zhou Y, Yang Y, Chang Y, Wu X.
    Life Sci; 2019 Sep 01; 232():116638. PubMed ID: 31288013
    [Abstract] [Full Text] [Related]

  • 15. Individual bile acids have differential effects on bile acid signaling in mice.
    Song P, Rockwell CE, Cui JY, Klaassen CD.
    Toxicol Appl Pharmacol; 2015 Feb 15; 283(1):57-64. PubMed ID: 25582706
    [Abstract] [Full Text] [Related]

  • 16. The influences of cholecystectomy on the circadian rhythms of bile acids as well as the enterohepatic transporters and enzymes systems in mice.
    Zhang F, Duan Y, Xi L, Wei M, Shi A, Zhou Y, Wei Y, Wu X.
    Chronobiol Int; 2018 May 15; 35(5):673-690. PubMed ID: 29381405
    [Abstract] [Full Text] [Related]

  • 17. Heterozygous knockout of Bile salt export pump ameliorates liver steatosis in mice fed a high-fat diet.
    Okushin K, Tsutsumi T, Ikeuchi K, Kado A, Enooku K, Fujinaga H, Yamauchi N, Ushiku T, Moriya K, Yotsuyanagi H, Koike K.
    PLoS One; 2020 May 15; 15(8):e0234750. PubMed ID: 32785220
    [Abstract] [Full Text] [Related]

  • 18. Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism.
    Hu X, Bonde Y, Eggertsen G, Rudling M.
    J Intern Med; 2014 Jan 15; 275(1):27-38. PubMed ID: 24118394
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of ileal apical but not basolateral bile acid transport reduces atherosclerosis in apoE⁻/⁻ mice.
    Lan T, Haywood J, Dawson PA.
    Atherosclerosis; 2013 Aug 15; 229(2):374-80. PubMed ID: 23880190
    [Abstract] [Full Text] [Related]

  • 20. Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH.
    Hernandez GV, Smith VA, Melnyk M, Burd MA, Sprayberry KA, Edwards MS, Peterson DG, Bennet DC, Fanter RK, Columbus DA, Steibel JP, Glanz H, Immoos C, Rice MS, Santiago-Rodriguez TM, Blank J, VanderKelen JJ, Kitts CL, Piccolo BD, La Frano MR, Burrin DG, Maj M, Manjarin R.
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar 01; 318(3):G582-G609. PubMed ID: 32003601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.